Fecal microbiota in patients with ankylosing spondylitis: Correlation with dietary factors and disease activityLi Zhang, Faming Pan, Shengqain Xu et al.|Clinica Chimica Acta|2019Cited by 65
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Xiaofeng Zeng, Ying Jiang et al.|Annals of the Rheumatic Diseases|2025Cited by 17
TERT promoter methylation predicts overall survival, immune cell infiltration and response to immunotherapy in clear cell renal cell carcinomaXinyu Guan, Long Qian, Jiahao Meng et al.|Clinical Epigenetics|2025Cited by 2